Report cover image

NA Pemphigus Vulgaris Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published Jun 01, 2023
Length 165 Pages
SKU # DAABD18055233

Description

NA Pemphigus Vulgaris Market - Industry Trends and Forecast to 2030


The North America pemphigus vulgaris market is expected to reach USD 313.87 million by 2030 from USD 165.49 million in 2022, growing at a CAGR of 8.4% during the forecast period of 2023 to 2030.

Market Segmentation:
North America Pemphigus Vulgaris Market, By Diagnosis and Treatment (Diagnosis, Treatment), Population Type (Pediatric, Adults, and Geriatric), End User (Hospitals, Specialty Clinics, Research Institutes, and Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy) - Industry Trends and Forecast to 2030
Overview of North America Pemphigus Vulgaris Market Dynamics:

Driver

• Rise in patients with rare diseases such as pemphigus vulgaris

Restraint

• High cost of treatment

Opportunity

• Rising healthcare facilities in the developing and underdeveloped countries

Market Players
The key market players operating in the Market are:

• F-Hoffmann La Roche Ltd.
• Sanofi
• Regeneron Pharmaceuticals Inc.
• F. Hoffmann-La Roche Ltd
• Pfizer Inc.
• Celltrion Healthcare Co., Ltd.
• AbbVie Inc.
• Novartis AG
• Amgen Inc.
• Merck & Co., Inc.
• AstraZeneca
• Teva Pharmaceutical Industries Ltd
• Lilly
• Zydus Group
• GSK plc.

Table of Contents

165 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market Application Coverage Grid
2.8 Product Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter Five Forces
4.3 Patent Analysis
4.4 Patient Flow Diagram
4.5 Key Pricing Strategies
4.6 Future Therapies
4.7 Key Patient Enrollment Strategies
5 Pipeline Analysis
6 Epidemiology
7 Industry Insights
8 North America Pemphigus Vulgaris Market: Regulations
9 Market Overview
9.1 Drivers
9.1.1 Emerging Treatment Options For Pemphigus Vulgaris
9.1.2 Growing Support Of Ngos For The Affected Patients
9.1.3 Awareness Regarding The Disease
9.2 Restraints
9.2.1 Strict Regulatory Guidelines
9.2.2 High Treatment Costs
9.3 Opportunities
9.3.1 Increasing Demand For Personalized Medicine
9.3.2 Increasing Healthcare Facilities
9.3.3 Digital Health Technologies For Treatment Management
9.4 Challenges
9.4.1 Adverse Effects Associated With Medications
9.4.2 Reimbursement And Coverage Policies
10 North America Pemphigus Vulgaris Market, By Diagnosis And Treatment
10.1 Overview
10.2 Treatment
10.2.1 Medications, By Type
10.2.1.1 Corticosteroids
10.2.1.2 Steroid- Sparing Immunosuppressant Drugs
10.2.1.2.1 Azathioprine
10.2.1.2.2 Mycophenalate Mofetil
10.2.1.2.3 Methotrexate
10.2.1.2.4 Cyclophosphamide
10.2.1.2.5 Mizoribine
10.2.1.2.6 Others
10.2.1.3 Anti- Inflammatory Agents
10.2.1.3.1 Diaminodyphenyl Sulfone
10.2.1.3.2 Tetracycline
10.2.1.3.3 Others
10.2.1.4 Biologics
10.2.1.5 Intravenous Immunoglobulin
10.2.1.6 Antibiotics
10.2.1.7 Antifungals
10.2.1.8 Antivirals
10.2.1.9 Other Medications
10.2.2 Medications, By Route Of Administration
10.2.2.1 Oral
10.2.2.2 Topical
10.2.2.3 Parenteral
10.2.2.4 Others
10.2.3 Medications, By Drug Type
10.2.3.1 Generic
10.2.3.2 Branded
10.3 Diagnosis
10.3.1 Skin Biopsy
10.3.2 Blood Test
10.3.3 Endoscopy
11 North America Pemphigus Vulgaris Market, By Population Type
11.1 Overview
11.2 Adults
11.3 Geriatric
11.4 Pediatric
12 North America Pemphigus Vulgaris Market, By End User
12.1 Overview
12.2 Hospitals
12.3 Specialty Clinics
12.4 Research Institutes
12.5 Others
13 North America Pemphigus Vulgaris Market, By Distribution Channel
13.1 Overview
13.2 Hospitals Pharmacy
13.3 Retail Pharmacy
13.4 Online Pharmacy
14 North America Pemphigus Vulgaris Market, By Region
14.1 North America
14.1.1 U.S.
14.1.2 Canada
14.1.3 Mexico
15 North America Pemphigus Vulgaris Market, Company Landscape
15.1 Company Share Analysis: North America
16 Swot Analysis
17 Company Profile
17.1 Abbvie Inc.
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Developments
17.2 Merck & Co., Inc.,
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Development
17.3 Sanofi
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Company Share Analysis
17.3.4 Product Portfolio
17.3.5 Recent Development
17.4 Regeneron Pharmaceuticals Inc.
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.5 Novartis Ag
17.5.1 Company Snapshot
17.5.2 Revenue Analysis
17.5.3 Company Share Analysis
17.5.4 Product Portfolio
17.5.5 Recent Development
17.6 Amgen Inc.
17.6.1 Company Snapshot
17.6.2 Revenue Analysis
17.6.3 Product Portfolio
17.6.4 Recent Developments
17.7 Astrazeneca
17.7.1 Company Snapshot
17.7.2 Revenue Analysis
17.7.3 Company Share Analysis
17.7.4 Product Portfolio
17.7.5 Recent Developments
17.8 Boehringer Ingelheim International Gmbh
17.8.1 Company Snapshot
17.8.2 Revenue Analysis
17.8.3 Product Portfolio
17.8.4 Recent Development
17.9 Celltrion Healthcare Co., Ltd
17.9.1 Company Snapshot
17.9.2 Revenue Analysis
17.9.3 Product Portfolio
17.9.4 Recent Developments
17.10 F. Hoffmann- La Roche Ltd.
17.10.1 Company Snapshot
17.10.2 Revenue Analysis
17.10.3 Product Portfolio
17.10.4 Recent Development
17.11 Fresenius Kabi Ag
17.11.1 Company Snapshot
17.11.2 Revenue Analysis
17.11.3 Product Portfolio
17.11.4 Recent Development
17.12 Gsk Plc
17.12.1 Company Snapshot
17.12.2 Revenue Analysis
17.12.3 Product Portfolio
17.12.4 Recent Development
17.13 Johnson & Johnson Services, Inc.
17.13.1 Company Snapshot
17.13.2 Revenue Analysis
17.13.3 Company Share Analysis
17.13.4 Product Portfolio
17.13.5 Recent Development
17.14 Lilly
17.14.1 Company Snapshot
17.14.2 Revenue Analysis
17.14.3 Product Portfolio
17.14.4 Recent Development
17.15 Pfizer Inc.
17.15.1 Company Snapshot
17.15.2 Revenue Analysis
17.15.3 Product Portfolio
17.15.4 Recent Development
17.16 Rakshit Drugs Pvt. Ltd
17.16.1 Company Snapshot
17.16.2 Product Portfolio
17.16.3 Recent Development
17.17 Teva Pharmaceutical Industries Ltd
17.17.1 Company Snapshot
17.17.2 Revenue Analysis
17.17.3 Product Portfolio
17.17.4 Recent Development
17.18 Zydus Group
17.18.1 Company Snapshot
17.18.2 Revenue Analysis
17.18.3 Product Portfolio
17.18.4 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables
Table 1 North America Pemphigus Vulgaris Market, Patent Analysis
Table 2 North America Pemphigus Vulgaris Market, Pipeline Analysis
Table 3 North America Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million)
Table 4 North America Treatment In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million)
Table 5 North America Treatment In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 6 North America Steroid- Sparing Immunosuppressant Drugs In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 7 North America Anti- Inflammatory Agents In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 8 North America Treatment In Pemphigus Vulgaris Market, By Route Of Administration, 2021-2030 (Usd Million)
Table 9 North America Treatment In Pemphigus Vulgaris Market, By Drug Type, 2021-2030 (Usd Million)
Table 10 North America Diagnosis In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million)
Table 11 North America Diagnosis In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 12 North America Pemphigus Vulgaris Market, By Population Type, 2021-2030 (Usd Million)
Table 13 North America Adults In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million)
Table 14 North America Geriatric In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million)
Table 15 North America Pediatric In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million)
Table 16 North America Pemphigus Vulgaris Market, By End User, 2021-2030 (Usd Million)
Table 17 North America Hospitals In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million)
Table 18 North America Specialty Clinics In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million)
Table 19 North America Research Institutes In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million)
Table 20 North America Others In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million)
Table 21 North America Pemphigus Vulgaris Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 22 North America Hospitals Pharmacy In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million)
Table 23 North America Retail Pharmacy In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million)
Table 24 North America Online Pharmacy In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million)
Table 25 North America Pemphigus Vulgaris Market, By Country, 2021-2030 (Usd Million)
Table 26 North America Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million)
Table 27 North America Treatment In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 28 North America Steroid-sparing Immunosuppressant Drugs In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 29 North America Anti-inflammatory Agents In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 30 North America Treatment In Pemphigus Vulgaris Market, By Route Of Administration, 2021-2030 (Usd Million)
Table 31 North America Treatment In Pemphigus Vulgaris Market, By Drug Type, 2021-2030 (Usd Million)
Table 32 North America Diagnosis In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 33 North America Pemphigus Vulgaris Market, By Population Type, 2021-2030 (Usd Million)
Table 34 North America Pemphigus Vulgaris Market, By End User, 2021-2030 (Usd Million)
Table 35 North America Pemphigus Vulgaris Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 36 U.S. Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million)
Table 37 U.S. Treatment In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 38 U.S. Steroid-sparing Immunosuppressant Drugs In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 39 U.S. Anti-inflammatory Agents In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 40 U.S. Treatment In Pemphigus Vulgaris Market, By Route Of Administration, 2021-2030 (Usd Million)
Table 41 U.S. Treatment In Pemphigus Vulgaris Market, By Drug Type, 2021-2030 (Usd Million)
Table 42 U.S. Diagnosis In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 43 U.S. Pemphigus Vulgaris Market, By Population Type, 2021-2030 (Usd Million)
Table 44 U.S. Pemphigus Vulgaris Market, By End User, 2021-2030 (Usd Million)
Table 45 U.S. Pemphigus Vulgaris Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 46 Canada Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million)
Table 47 Canada Treatment In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 48 Canada Steroid-sparing Immunosuppressant Drugs In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 49 Canada Anti-inflammatory Agents In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 50 Canada Treatment In Pemphigus Vulgaris Market, By Route Of Administration, 2021-2030 (Usd Million)
Table 51 Canada Treatment In Pemphigus Vulgaris Market, By Drug Type, 2021-2030 (Usd Million)
Table 52 Canada Diagnosis In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 53 Canada Pemphigus Vulgaris Market, By Population Type, 2021-2030 (Usd Million)
Table 54 Canada Pemphigus Vulgaris Market, By End User, 2021-2030 (Usd Million)
Table 55 Canada Pemphigus Vulgaris Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 56 Mexico Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million)
Table 57 Mexico Treatment In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 58 Mexico Steroid-sparing Immunosuppressant Drugs In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 59 Mexico Anti-inflammatory Agents In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 60 Mexico Treatment In Pemphigus Vulgaris Market, By Route Of Administration, 2021-2030 (Usd Million)
Table 61 Mexico Treatment In Pemphigus Vulgaris Market, By Drug Type, 2021-2030 (Usd Million)
Table 62 Mexico Diagnosis In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million)
Table 63 Mexico Pemphigus Vulgaris Market, By Population Type, 2021-2030 (Usd Million)
Table 64 Mexico Pemphigus Vulgaris Market, By End User, 2021-2030 (Usd Million)
Table 65 Mexico Pemphigus Vulgaris Market, By Distribution Channel, 2021-2030 (Usd Million)
List Of Figures
Figure 1 North America Pemphigus Vulgaris Market: Segmentation
Figure 2 North America Pemphigus Vulgaris Market: Data Triangulation
Figure 3 North America Pemphigus Vulgaris Market: Droc Analysis
Figure 4 North America Pemphigus Vulgaris Market: North America Vs Regional Market Analysis
Figure 5 North America Pemphigus Vulgaris Market: Company Research Analysis
Figure 6 North America Pemphigus Vulgaris Market: Interview Demographics
Figure 7 North America Pemphigus Vulgaris Market: Market Application Coverage Grid
Figure 8 North America Pemphigus Vulgaris Market: Dbmr Market Position Grid
Figure 9 North America Pemphigus Vulgaris Market: Vendor Share Analysis
Figure 10 North America Pemphigus Vulgaris Market: Segmentation
Figure 11 The Emerging Treatment Options For The Pemphigus Vulgarisis Expected To Drive The Growth Of The North America Pemphigus Vulgaris Market From 2023 To 2030
Figure 12 The Diagnosis And Treatment Segment Is Expected To Account For The Largest Share Of The North America Pemphigus Vulgaris Market In 2023 And 2030
Figure 13 Patient Flow Description Of Pemphigus Vulgaris:-
Figure 14 Drivers, Restraints, Opportunities, And Challenges Of North America Pemphigus Vulgaris Market
Figure 15 North America Pemphigus Vulgaris Market: By Diagnosis And Treatment, 2022
Figure 16 North America Pemphigus Vulgaris Market: By Diagnosis And Treatment, 2023-2030 (Usd Million)
Figure 17 North America Pemphigus Vulgaris Market: By Diagnosis And Treatment, Cagr (2023-2030)
Figure 18 North America Pemphigus Vulgaris Market: By Diagnosis And Treatment, Lifeline Curve
Figure 19 North America Pemphigus Vulgaris Market: By Population Type, 2022
Figure 20 North America Pemphigus Vulgaris Market: By Population Type, 2023-2030 (Usd Million)
Figure 21 North America Pemphigus Vulgaris Market: By Population Type, Cagr (2023-2030)
Figure 22 North America Pemphigus Vulgaris Market: By Population Type, Lifeline Curve
Figure 23 North America Pemphigus Vulgaris Market: By End User, 2022
Figure 24 North America Pemphigus Vulgaris Market: By End User, 2023-2030 (Usd Million)
Figure 25 North America Pemphigus Vulgaris Market: By End User, Cagr (2023-2030)
Figure 26 North America Pemphigus Vulgaris Market: By End User, Lifeline Curve
Figure 27 North America Pemphigus Vulgaris Market: By Distribution Channel, 2022
Figure 28 North America Pemphigus Vulgaris Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 29 North America Pemphigus Vulgaris Market: By Distribution Channel, Cagr (2023-2030)
Figure 30 North America Pemphigus Vulgaris Market: By Distribution Channel, Lifeline Curve
Figure 31 North America Pemphigus Vulgaris Market: Snapshot (2022)
Figure 32 North America Pemphigus Vulgaris Market: By Country (2022)
Figure 33 North America Pemphigus Vulgaris Market: By Country (2023 & 2030)
Figure 34 North America Pemphigus Vulgaris Market: By Country (2022 & 2030)
Figure 35 North America Pemphigus Vulgaris Market: By Diagnosis And Treatment (2023-2030)
Figure 36 North America Pemphigus Vulgaris Market: Company Share 2022 (%) 108

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us